| Term 
 
        | Acetylcholine (Miochol-E) |  | Definition 
 
        | Direct Acting Muscarinic Agonist |  | 
        |  | 
        
        | Term 
 
        | Methacholine (Provocholine) |  | Definition 
 
        | Direct Acting Muscarinic Agonist 
pulmonary function testing in asthma |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Direct Acting Muscarinic Agonist 
GI motilityTreat urine retention |  | 
        |  | 
        
        | Term 
 
        | pilocarpine (Salagen/Ocusert Pilo) |  | Definition 
 
        | Direct Acting Muscarinic Agonist 
Treat glaucomaTreat xerostomia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Reversible cholinesterase inhibitor |  | 
        |  | 
        
        | Term 
 
        | physostigmine/eserine (Antilirium) |  | Definition 
 
        | Reversible cholinesterase inhibitor 
Antidote to antimuscarinic OD |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Reversible cholinesterase inhibitor |  | 
        |  | 
        
        | Term 
 
        | pyridostigmine (Mestinon) |  | Definition 
 
        | Reversible cholinesterase inhibitor 
Treat MGPre-exposure protection by army |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Reversible cholinesterase inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Reversible cholinesterase inhibitor |  | 
        |  | 
        
        | Term 
 
        | carbamate insecticides (Carbaryl) |  | Definition 
 
        |   reversible cholinesterase inhibitor |  | 
        |  | 
        
        | Term 
 
        | Organophosphate insecticides (Parathion, Malathion) |  | Definition 
 
        | Irreversible cholinesterase inhibitors |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Irreversible cholinesterase inhibitors |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | cGMP phosphodiesterase inhibitors |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | cGMP phosphodiesterase inhibitors |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | cGMP phosphodiesterase inhibitors |  | 
        |  | 
        
        | Term 
 
        | Pralidoxime/2-p AM (Protopam) |  | Definition 
 
        | Cholinesterase Reactivator 
Counters organophosphates (given within 2 hours)Counters nerve agents like Sarin |  | 
        |  | 
        
        | Term 
 
        | Atropine, Hyoscyamine and Homatropine |  | Definition 
 
        | Muscarinic antagonists (Anticholinergics) 
Antidote to ACH ODPreoperative to block vagal to heart |  | 
        |  | 
        
        | Term 
 
        | scopolamine and methscopolamine |  | Definition 
 
        | Muscarinic antagonists (Anticholinergics) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic antagonists (Anticholinergics) 
Intestinal antispasmatic for IBS |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic antagonists (Anticholinergics) 
GI antispasmdic to treat IBS |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic antagonists (Anticholinergics) 
anesthetic to dry secretionsinhibit vagal reflexes |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic antagonists (Anticholinergics) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic antagonists (Anticholinergics) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic antagonists (Anticholinergics) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic antagonists (Anticholinergics) 
Treat urinary incontinence |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Selective β1-agonist 
Treat cardiogenic shockStart heart back up again |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Selective α1-agonists 
Dilate eyes without causing cycloplagia |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect-acting Sympathomimetics |  | 
        |  | 
        
        | Term 
 
        | Pseudoephedrine (Sudafed) |  | Definition 
 
        | Indirect-acting Sympathomimetics 
Treat stress induced urinary incontinance |  | 
        |  | 
        
        | Term 
 
        | Acebutolol (Sectral) 
BlocksPartial agonist?Membrane stabalizing?Lipid solubility?   |  | Definition 
 
        | 
β1 blockerpartial agonistmembrane stabilizingLow lipid solubility |  | 
        |  | 
        
        | Term 
 
        | Atenolol (Tenormin) 
BlocksPartial agonist?Membrane stabalizing?Lipid solubility? |  | Definition 
 
        | 
β1 blockerNot partial agonistNot membrane stabalizingLow lipid solubility |  | 
        |  | 
        
        | Term 
 
        | Esmolol (Brevibloc) 
BlocksPartial agonist?Membrane stabalizing?Lipid solubility?   |  | Definition 
 
        | 
Blocks β1Not partial agonistNot membrane stabalizingLow lipid solubility   |  | 
        |  | 
        
        | Term 
 
        | Metoprolol (Lopressor, Toprol XL) 
BlocksPartial agonist?Membrane stabalizing?Lipid solubility?   |  | Definition 
 
        | 
Blocks β1Not partial agonistMembrane stabalizingMedium Lipid solubility Worsens raynaulds   |  | 
        |  | 
        
        | Term 
 
        | Nadolol (Corgard) 
BlocksPartial agonist?Membrane stabalizing?Lipid solubility?   |  | Definition 
 
        | 
Blocks β1 & β2Not Partial agonistNon Membrane stabalizingLow lipid solubility   |  | 
        |  | 
        
        | Term 
 
        | Pindolol 
BlocksPartial agonist?Membrane stabalizing?Lipid solubility?   |  | Definition 
 
        | 
Blocks β1, β2Partial agonistMembrane stabalizingMedium lipid solubility?   |  | 
        |  | 
        
        | Term 
 
        | Propranolol (Inderal-LA) 
BlocksPartial agonist?Membrane stabalizing?Lipid solubility?   |  | Definition 
 
        | 
Blocks β1, β2not Partial agonistMembrane stabalizingHigh lipid solubility   |  | 
        |  | 
        
        | Term 
 
        | Timolol (Timoptic) 
BlocksPartial agonist?Membrane stabalizing?Lipid solubility?   |  | Definition 
 
        | 
Blocks β1,β2Not partial agonistNot membrane stabalizingMedium lipid solubilityTreat glaucoma   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Blocks α, βTreat hypertension   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Non selective α1α2 blockerTreat pheochromocytomaCounter tissue necrosis counter oral anesthetics |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Selective α1 blockerTreat hypertensionTreat BPHTreat raynaudstreat PTSD |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Selective α1 blockerTreat hypertensionTreat BPHTreat raynaudstreat PTSD |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Selective α1 blockerTreat BPH |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
peripheral acting sympathetic neuronal blockerDecrease NE, Da into vessicles.  LALowers BP |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Centrally acting sympathetic neuronal blockerprodrug. α agonist at CNS to lowr outflow of sympatheti activitylower renin releasetreat hypertension during pregnancyinduce autoimmune disorders |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Centrally acting sympathetic neuronal blockerpatchlowers BP, migraine, ADHD, PTSD, hot flashes |  | 
        |  | 
        
        | Term 
 
        | Nicotine 
HeartVesselsEyeGIBladder |  | Definition 
 
        | (Ganglionic stimulant) 
Heart: Tachycardia, ↓ contractilityVessels: vasodilation, ↓TPREye: Mydriasis, cycloplegiaGI: ↓tone, motility, secretionBladder: urine retention   |  | 
        |  | 
        
        | Term 
 
        | l-dopa + Carbidopa (Sinemet) |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Dopaminergic agentsecond choice, less on-offdecreases lactation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Dopaminergic agentAlso usefull for restless leg |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Dopaminergic agentalso usefull for RLS |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Dopaminergic agentStimulate release of dopamine. |  | 
        |  | 
        
        | Term 
 
        | Selegiline/Deprenyl (Eldepryl, Zelapar) |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Diphenhydramine (benadryl) |  | Definition 
 
        | 
Antihistamineblocks muscarinic as SE   |  | 
        |  | 
        
        | Term 
 
        | Hydroxychloroquine Sulfate (Plaquenil) |  | Definition 
 
        | 
MOA unknownDrug deposits in tissueEye toxicity irreversible |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Inhibit macrophage phagocytosis and enzyme releaseDiarrhea, Dermatologic, stomatitis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
ImmunosuppressiveAnorexia, HA, NVNeutrapenia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Inhibit pyrimidine synthesisInhibit dihydroorotate dehydrogenaseGI, Hepatotoxicity, Hematological, Hypersensitivity |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Dimeric fusion protein          Human + HumanBinds TNF α/βHypersensitivity infections & sepsis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Chimeric Human + Murineneutralizes TNFα onlyHypersensitivity, immunosuppressive, |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
ProdrugNon-specific alkylating agentInhibit signal 3 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
AntimetaboliteSignal 3Affects adenosine deaminase |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Inhibit dihydropholate reductaseSignal 3 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
inhibit calcineurin Phosphatasesinhibit release of IL2Signal 1Nephrotoxic |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Inhibit Inosine monophosphate Dehydrogenase.  purine metabolismSignal 3 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Murine clonal antibodyBlocks CD3Signal 1 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
suppresses Immune response of Rh-negative individual to Rh-positive RBCSignal 1 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Passive immunity increasedSignal 1for immunosuppressed patients |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Growth of stem cells into RBCTreats anemia of chronic diseases (AIDS, Cancer, before surgery) |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Growth of granulocytes and macrophages |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Alkylating agentNonspecific |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   
Alkylating agentNonspecific |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class 1A Slows conduction velocity of phase 0 ↑ AP duration ↑ refractory period (interact medium with Na channels) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class 1A (inhibits Na, metabolite inhibits K) Slows conduction velocity of phase 0 ↑ AP duration ↑ refractory period (interact medium with Na channels) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CLass 1B Slows conduction velocity of phase 0 ↓ AP duration ↓ Refractory period (Interact fast with Na channels) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class 1C Greatly Slows conduction velocity of phase 0 ↑ AP duration ↑ refractory period (interact slowly with Na channels) |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Inhibit Thromboxane synthesis (Cox1 inhibitor) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Inhibits phosphodiesterase↑cAMP↓ TXA2 production.Blocks platelet adhesion to vessels |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Inhibit ADP binding to platelet receptor (irreversible) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Binds Antithrombin III, ↑ activity |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Blocks vitamin KInhibit synthesis of factors & anticoagulent proteins. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Binds & blocks thrombinfor patients with heparin induced thrombocytopenia. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Binds and activates plasminogen(Antigenic) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Binds and activates plasminogen(non-antigenic) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
causes plasminogen to have greater affinity for fibrin. |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Phytonadione (Aquamephyton) (vitamin K) |  | Definition 
 
        | 
Counter CoumadinNewborn hemorrhagic disease |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Carbonic Anhydrase inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Ethacrynic Acid (Edecrin) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Chlorthalidone (Hygroton) |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | K-sparing Na channel inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | K-sparing Na channel inhibitor |  | 
        |  | 
        
        | Term 
 
        | Spironolactone (Aldactone) |  | Definition 
 
        | K-sparing aldosterone antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | K-sparing aldosterone antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | α1/β Blocker and NO-releasing β1 blocker |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Direct Arteriolar Dilator |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Direct Arteriolar Dilator |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Calcium Channel Blocker (Heart) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Calcium Channel Blocker (Heart) |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Angiotensin II Receptor Blocker |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Angiotensin II Receptor Blocker |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cholesterol absorption inhibitor |  | 
        |  | 
        
        | Term 
 
        | Cholestyramine (Questran) |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Direct Vasodilator (Preload) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Direct Vasodilator (Preload) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | HMG-COA Reductase Inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | HMG-COA Reductase Inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | HMG-COA Reductase Inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Fibric Acid Analogue (Fibrates) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Fibric Acid Analogue (Fibrates) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | stimulate release of insulin |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | stimulate release of insulin (Blood glucose concentration dependent) |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Increase glucose transporters through PPAR |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Increase glucose transporters through PPAR |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Glucosidease inhibitor delays digestion of sugars |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Incretin mimetic ↑ Glucose dependent insulin release ↓ Glucagon secretion ↓ Gastric emptying feeling of fullness   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | DPP-IV inhibitor inhibits degredation of incretin |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Amylin analog Slows gastric emptying Inhibits glucagon secretion Feeling full |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Benzodiazepine antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Good for recovering alcoholics |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Agonist at melatonin receptors |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Non Benzi sleap aid Enhances effects of GABA |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Blocks DA, ↑ACH.  (High EPS, low Anticholinergic)Hiccup, tic, mania, scitzo |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Atypic AntipsychoticBlocks D4 & 5HTAgranulocytosis, high Anticholinergicno EPS |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Atypic antipsychoticPartial agonist at D2 and 5HT |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
TricyclicBlocks reuptake of NE & SerotoninPain from peripheral neuropathy, Migraine, Muscarinic antagonist, enuresis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
TricyclicBlocks reuptake of NE & Serotonin |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
SSRIShort acting, no metabolites |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
5HT reuptake blocker & receptor blockerVery sedating |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Decrease contraction (week 33) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Treat osteoporosis (SERM) |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Ethylene glycol poisoning |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Penicillinase resistant (anti Staph) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Penicillinase resistant (anti Staph) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Penicillinase resistant (anti Staph) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Extended spectrum penicillin |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Extended spectrum penicillin |  | 
        |  | 
        
        | Term 
 
        | Ticarcillin + Clavulanate |  | Definition 
 
        | Antipseudomonal penicillin |  | 
        |  | 
        
        | Term 
 
        | Piperacillin + Tazobactam |  | Definition 
 
        | Antipseudomonal penicillin |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Bind D-alanyl D-alanine, inhibit cell wallchange in cell wall enzymes |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Reduced form damages bacterial DNA |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Cationic detergentinhibit from entering cell |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Binds intracellular molecules Metrosexuals like hugs, they bind to everyone |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inhibit bacterial cell wall synthesis |  | 
        |  | 
        
        | Term 
 
        | Quinuprestin/Dalfopristin |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Albendazole & Mebendazole MOA: |  | Definition 
 
        | Inhibit microtubule mediated glucose uptake   "bend the tubes so the helminths can't suck up sugar" |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Depolarizing neuromuscular blockade   "When I see Pam, I am paralized" |  | 
        |  | 
        
        | Term 
 
        | How does prazuquantel work? |  | Definition 
 
        | 
Ca influx: contractions then paralysisShistosomes become dislodged In CA I recieved a present.  I was so excited that I was contracting, then I lost interest and became still like paralysis |  | 
        |  | 
        
        | Term 
 
        | What is Amantadine used to treat? |  | Definition 
 
        | Influenza A XC: Parkinson's (If a man flew, then he is superman) |  | 
        |  | 
        
        | Term 
 
        | What is ribavirin used to treat? |  | Definition 
 
        | 
Respiratory syncytial viral infectionChronic hepatitis C (+ IF α-2A) the ribbon wraps around you, so you can't C and you can't breath |  | 
        |  | 
        
        | Term 
 
        | What is trifluridine used to treat? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What is Acyclovir used to treat? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What is Gancyclovir used for? |  | Definition 
 
        | 
Cytomegalovirus infections : you can sit down in that general site over there" |  | 
        |  | 
        
        | Term 
 
        | What is foscarnate used for? |  | Definition 
 
        | 
Cytomegalovirus for AIDs patients (AIDs haunts me like a scar, ) |  | 
        |  | 
        
        | Term 
 
        | What is interferon used to treat (as it pertains to antivirals I)? |  | Definition 
 
        | 
WartsHepatitis B and CHerpesperatoconjunctivitis (the plagues of egypt comanded by mosus interfered with Pharo's plans.  They included frog warts and liver disease.  All this happened BC)
 
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Inhibit mycolic acid biosynthesisAnalog of B3   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Suppress RNA synthesisDrug-enzyme complex   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
converted to POA.  ↓PH = less growth The pirates make acid |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Binds DNA inhibits growth throw a cloth over him, so he can't expand |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  |